Target intelligence / Profile preview

Iron ions (Fe2+/Fe3+)

Target
Fe2+/Fe3+
Molecular classification
Metal ion, Redox-active metal
01

Overview

Iron ions, particularly in their ferrous (Fe2+) and ferric (Fe3+) states, serve as critical mediators of cellular redox chemistry. In the context of Fenton chemistry, ferrous iron reacts with hydrogen peroxide to produce the hydroxyl radical, one of the most reactive and damaging oxygen species in biological systems (Winterbourn, 1995, PubMed: 8597169). This reaction is a key driver of oxidative stress and is the fundamental mechanism underlying ferroptosis, a form of regulated cell death characterized by iron-dependent lipid peroxidation (Dixon et al., 2012, PubMed: 22632970). While iron is essential for functions such as oxygen transport and DNA synthesis, an excess of the labile iron pool can lead to tissue damage in conditions like hemochromatosis, thalassemia, and various neurodegenerative diseases (Mobarra et al., 2016, PubMed: 27822364). Pharmacological intervention typically focuses on iron chelation therapy, using agents like deferoxamine or deferasirox to sequester redox-active iron and prevent the initiation of radical-generating cycles (Koppenol & Hider, 2019, PubMed: 30213779). Consequently, managing iron homeostasis is a vital therapeutic target for mitigating oxidative injury and controlling cell death pathways in diverse clinical settings.

Other names
Ferrous ironFerric ironLabile iron poolRedox-active ironFree ironFenton reagents
02

Mechanism of action

Chelation of redox-active iron to prevent the formation of hydroxyl radicals via the Fenton reaction, thereby reducing oxidative stress and lipid peroxidation.

03

Biological functions

Oxygen transportElectron transportDNA synthesisReactive oxygen species (ROS) generationCell signalingCofactor for heme and non-heme proteins
04

Disease associations

Iron overloadHemochromatosisNeurodegenerative diseaseCancerIschemia-reperfusion injuryFerroptosis-mediated cell deathThalassemia
05

Safety considerations

Systemic iron deficiencyOtotoxicityNephrotoxicityAgranulocytosisGastrointestinal disturbances
06

Interacting drugs

Deferoxamine

4 more in the full profile.

07

Biomarkers

Serum ferritinTransferrin saturationLabile iron pool (LIP)Malondialdehyde (MDA)4-Hydroxynonenal (4-HNE)

Beyond the preview

Go deeper on Iron ions (Fe2+/Fe3+).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Iron ions (Fe2+/Fe3+).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call